# Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine

> **NCT04349553** · PHASE1 · COMPLETED · sponsor: **Prokarium Ltd** · enrollment: 46 (actual)

## Conditions studied

- Enteric Fever

## Interventions

- **BIOLOGICAL:** ZH9PA and ZH9
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** ZH9PA

## Key facts

- **NCT ID:** NCT04349553
- **Lead sponsor:** Prokarium Ltd
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-12-16
- **Primary completion:** 2020-09-28
- **Final completion:** 2021-02-15
- **Target enrollment:** 46 (ACTUAL)
- **Last updated:** 2025-08-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04349553

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04349553, "Study to Evaluate the Safety, Tolerability and Immunogenicity of a Potential Enteric Fever Vaccine". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04349553. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*